AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
West Pharmaceutical Services, Inc.
XNYS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001S5XK22
390.30▼ 6.39 (-1.61%)
As of 2026-11-20
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
396.69
Day's Range
387.71 – 400.90
52-Week Range
223.83 – 438.27
Volume
595.0K
Avg Volume
675.1K
Share Statistics
Shares Outstanding
Employees
10.8K
Exchange
XNYS
Listed
1973-01-02
Share count as of October 21, 2026

West Pharmaceutical Services, Inc. (WST) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about West Pharmaceutical Services, Inc. (WST)
What is West Pharmaceutical Services, Inc.'s Market Cap?
West Pharmaceutical Services, Inc.'s Market Cap is $27.2B, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s Enterprise Value?
West Pharmaceutical Services, Inc.'s Enterprise Value is $26.9B, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s Trailing P/E?
West Pharmaceutical Services, Inc.'s Trailing P/E is 42.6×, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s Price / Sales?
West Pharmaceutical Services, Inc.'s Price / Sales is 8.0×, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s EV / Revenue?
West Pharmaceutical Services, Inc.'s EV / Revenue is 7.9×, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s EV / EBITDA?
West Pharmaceutical Services, Inc.'s EV / EBITDA is 27.9×, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s Revenue (TTM)?
West Pharmaceutical Services, Inc.'s Revenue (TTM) is $3.4B, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s Net Income (TTM)?
West Pharmaceutical Services, Inc.'s Net Income (TTM) is $638.9M, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s EBITDA?
West Pharmaceutical Services, Inc.'s EBITDA is $964.5M, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s Diluted EPS (TTM)?
West Pharmaceutical Services, Inc.'s Diluted EPS (TTM) is 9.17, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · WSTAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemSep 30, 2026Jun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Net sales
YoY growth+8.7%+13.8%+21.0%+7.5%
Cost of goods and services sold
Gross profit
% of revenue39.7%37.7%35.1%37.8%
Research and development
Selling, general and administrative expenses
Other expense (income) (Note 14)
Operating profit
% of revenue30.6%20.5%21.0%19.5%
Interest expense, net
Interest income
Other nonoperating expense (income)
Income before income taxes and equity in net income of affiliated companies
Net income
% of revenue24.5%17.7%16.4%16.4%
Basic (in dollars per share)
Diluted (in dollars per share)